(Q37164691)

18 August 2017

1 reference

title

Ambroxol: a CNS drug? (English)

1 reference

18 August 2017

Thomas Weiser

1

1 reference

18 August 2017

publication date

1 January 2008

1 reference

CNS Neuroscience & Therapeutics

18 August 2017

published in

1 reference

18 August 2017

volume

14

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

17-24

1 reference

International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

The analgesic response to intravenous lidocaine in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Central nervous system and cardiac effects from long-acting amide local anesthetic toxicity in the intact animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Mexiletine. A review of its therapeutic use in painful diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Depressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Depressant effect of ambroxol on stimulated functional responses and cell death in rat alveolar macrophages exposed to silica in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

The role of inflammation in CNS injury and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

In vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Cell-specific modulation of surfactant proteins by ambroxol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

In vitro and in vivo antioxidant activity of ambroxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Ambroxol Inhibits Na+ Absorption by Canine Airway Epithelial Cells in Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Comparison of the effects of four Na+ channel analgesics on TTX-resistant Na+ currents in rat sensory neurons and recombinant Nav1.2 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Inhibition of tetrodotoxin (TTX)-resistant and TTX-sensitive neuronal Na(+) channels by the secretolytic ambroxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Reflexes from the lungs and airways: historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

In vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na(+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2007.00032.X

Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells

21 January 2018

1 reference

12 December 2020

BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.

1 reference

12 December 2020

Differential interaction of R-mexiletine with the local anesthetic receptor site on brain and heart sodium channel alpha-subunits.

1 reference

12 December 2020

The involvement of the tetrodotoxin-resistant sodium channel Na(v)1.8 (PN3/SNS) in a rat model of visceral pain.

1 reference

12 December 2020

Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept

1 reference

12 December 2020

Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials regarding the local anaesthetic properties

1 reference

12 December 2020

Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs

1 reference

12 December 2020

Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs

1 reference

12 December 2020

Ambroxol for the prevention of acute upper respiratory disease

1 reference

12 December 2020

Role of decreased sensory neuron membrane calcium currents in the genesis of neuropathic pain.

1 reference

12 December 2020

Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients

1 reference

12 December 2020

Mucociliary clearance in early simple chronic bronchitis

1 reference

12 December 2020

An alternative to steroids for prevention of respiratory distress syndrome (RDS): multicenter controlled study to compare ambroxol and betamethasone

1 reference

12 December 2020

[The pharmacokinetics and bioequivalence of various dosage forms of ambroxol]

1 reference

12 December 2020

Pharmacological study on the bromhexine metabolite ambroxol (author's transl)

1 reference

12 December 2020

Ambroxol, comparative studies of pharmacokinetics and biotransformation in rat, rabbit, dog and man (author's transl)

1 reference

12 December 2020

The local anesthetic effect of NA872-containing eyedrops

1 reference

12 December 2020

Comparative CNS toxicity of lidocaine, etidocaine, bupivacaine, and tetracaine in awake dogs following rapid intravenous administration.

1 reference

12 December 2020

Antenatal ambroxol usage in the prevention of infant respiratory distress syndrome. Beneficial and adverse effects

1 reference

12 December 2020

The antioxidative activity of the mucoregulatory agents: ambroxol, bromhexine and N-acetyl-L-cysteine. A pulse radiolysis study

1 reference

12 December 2020

Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro

1 reference

12 December 2020

10.1111/J.1755-5949.2007.00032.X

Identifiers

DOI

1 reference

18 August 2017

1 reference